FDA delays OTC birth control pill decision

02/17/2004 | Houston Chronicle (tiered subscription model)

The FDA said it will need an additional 90 days to review whether the morning-after pill should be available over-the-counter because it's concerned about teenagers' use of the product. Advocates of the drug's over-the-counter status say the FDA is responding to political rather than scientific concerns.

View Full Article in:

Houston Chronicle (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ